Katana Labs, established in April 2023 in Germany, offers a cutting-edge cloud- and AI-based image analysis pipeline for cancer diagnostics, targeting clinical pathology and biotech R&D workflows. The company’s flagship product, PAIKON, is an AI-powered, cloud-based platform designed to revolutionize cancer diagnostics with advanced image analysis software, featuring a browser-based graphical user interface. Leveraging the expertise of experts in image analysis and deep learning, Katana Labs focuses to significantly reduce pathologists’ analysis time.

Management &

Advisors

Nicolaus Widera

COO

Linkedin

Walter de Back, PhD

CTO

Linkedin

Falk Zakrzewski, PhD

CEO

Linkedin

Prof. Martin Weigert, PhD

Lead Scientific Advisor

Google Scholar

Associate Prof.

Ulrich Sommer, MD

Lead Medical Advisor

Linkedin